A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

Completed

Plain-English translation of NCT03662542 on ClinicalTrials.gov ↗ · Source last updated December 2023 · How we translate trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(82 sites)

United States

Precision Research Institute, San Diego, California

Peak Gastroenterology Associates, Colorado Springs, Colorado

GCP Clinical Research, Tampa, Florida

Gastrointestinal Specialists of Georgia, Marietta, Georgia

Indiana University, Indianapolis, Indiana